• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肾小球肾炎患者血浆组织因子及组织因子途径抑制物

Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.

作者信息

Lizakowski Slawomir, Zdrojewski Zbigniew, Jagodzinski Piotr, Rutkowski Boleslaw

机构信息

Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.

出版信息

Scand J Urol Nephrol. 2007;41(3):237-42. doi: 10.1080/00365590601016511.

DOI:10.1080/00365590601016511
PMID:17469034
Abstract

OBJECTIVE

Nephrotic syndrome (NS) is associated with numerous blood coagulation abnormalities and a marked predisposition to thromboembolism. Fibrin formation within the glomeruli occurs in various forms of human and experimental glomerulonephritis and may play an important role in progressive glomerular injury. The aim of this study was to measure the plasma concentrations of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) and intravascular thrombin generation markers and to analyze their relationships in patients with primary glomerulonephritis.

MATERIAL AND METHODS

The study population comprised 57 patients (mean age 35.2 years; range 18-63 years) with primary glomerulonephritis: 36 with NS (NS group) and 21 without (non-NS group). The control group consisted of 24 sex- and age-matched healthy volunteers. TF and TFPI antigen, prothrombin fragment F 1+2 (PF 1+2) and thrombin-antithrombin III complex (TAT) concentrations in plasma were estimated using commercially available kits.

RESULTS

Serum TF and TFPI concentrations in both the NS and non-NS groups were higher than those observed in the control group. Moreover, there were significant differences in TF and TFPI concentrations between the NS and non-NS groups. TF:TFPI ratios in both the examined groups were constant and significantly higher than those in the control group. Positive correlations between TF and both PF 1+2 and TAT concentrations in the total cohort of patients were shown. Furthermore, a positive correlation between TF and TFPI concentrations was observed.

CONCLUSIONS

Our data support the hypothesis concerning activation of coagulation pathways in patients with primary glomerulonephritis. An inadequate TFPI concentration as a result of an elevated TF:TFPI ratio characterizes not only patients with clinical manifestations of NS but also patients with mild proteinuria.

摘要

目的

肾病综合征(NS)与多种血液凝固异常及血栓栓塞的显著易感性相关。肾小球内纤维蛋白形成见于各种人类和实验性肾小球肾炎,可能在进行性肾小球损伤中起重要作用。本研究的目的是测量原发性肾小球肾炎患者血浆组织因子(TF)和组织因子途径抑制物(TFPI)浓度以及血管内凝血酶生成标志物,并分析它们之间的关系。

材料与方法

研究人群包括57例原发性肾小球肾炎患者(平均年龄35.2岁;范围18 - 63岁):36例患有NS(NS组),21例未患(非NS组)。对照组由24名年龄和性别匹配的健康志愿者组成。使用市售试剂盒测定血浆中TF和TFPI抗原、凝血酶原片段F 1+2(PF 1+2)和凝血酶 - 抗凝血酶III复合物(TAT)的浓度。

结果

NS组和非NS组的血清TF和TFPI浓度均高于对照组。此外,NS组和非NS组之间的TF和TFPI浓度存在显著差异。两个研究组的TF:TFPI比值恒定且显著高于对照组。在全部患者队列中,TF与PF 1+2和TAT浓度之间呈正相关。此外,还观察到TF与TFPI浓度之间呈正相关。

结论

我们的数据支持原发性肾小球肾炎患者凝血途径激活的假说。TF:TFPI比值升高导致TFPI浓度不足不仅是NS临床表现患者的特征,也是轻度蛋白尿患者的特征。

相似文献

1
Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.原发性肾小球肾炎患者血浆组织因子及组织因子途径抑制物
Scand J Urol Nephrol. 2007;41(3):237-42. doi: 10.1080/00365590601016511.
2
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.缺血性心脏病患者体内组织因子及组织因子途径抑制物循环水平升高。
Thromb Haemost. 1998 Mar;79(3):495-9.
3
Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.人类非新月体性肾小球肾炎中的组织因子及其抑制剂——免疫染色与血浆及尿液水平的比较
Nephrol Dial Transplant. 2006 Dec;21(12):3450-7. doi: 10.1093/ndt/gfl365. Epub 2006 Sep 17.
4
Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.组织因子、组织途径因子抑制剂与慢性肢体缺血患者动脉粥样硬化的危险因素:初步研究
Int Angiol. 2008 Aug;27(4):296-301.
5
Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.关于体外循环期间凝血酶生成机制的另一种观点:组织因子途径抑制物的作用。
J Cardiothorac Vasc Anesth. 2001 Feb;15(1):60-4. doi: 10.1053/jcan.2001.20278.
6
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者的血浆组织因子和组织因子途径抑制物水平
Am J Hematol. 1996 Jul;52(3):165-70. doi: 10.1002/(SICI)1096-8652(199607)52:3<165::AID-AJH5>3.0.CO;2-R.
7
Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.胎儿死亡患者母体血小板激活、凝血酶过度生成以及羊水组织因子免疫反应性和功能活性升高的证据。
J Matern Fetal Neonatal Med. 2009 Aug;22(8):672-87. doi: 10.1080/14767050902853117.
8
Pneumonectomy due to lung cancer results in a more pronounced activation of coagulation system than lobectomy.肺癌导致的肺切除术比肺叶切除术更能显著激活凝血系统。
Eur J Cardiothorac Surg. 2009 Dec;36(6):1064-8. doi: 10.1016/j.ejcts.2009.04.070. Epub 2009 Aug 18.
9
Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.重度卵巢过度刺激综合征中的高凝状态、高组织因子水平及低组织因子途径抑制物水平:与临床结局的可能关联
Blood Coagul Fibrinolysis. 2003 Apr;14(3):277-82. doi: 10.1097/01.mbc.0000061296.28953.d0.
10
[Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].[不同疾病患者血浆组织因子及组织因子途径抑制物的行为分析]
Rinsho Ketsueki. 1996 Sep;37(9):794-8.

引用本文的文献

1
Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2.2型糖尿病患者发生高凝状态的低风险
J Zhejiang Univ Sci B. 2015 Sep;16(9):788-95. doi: 10.1631/jzus.B1500066.
2
Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome.肾病综合征患儿的组织因子途径抑制剂
SAJCH. 2011 Dec;5(4):107-111.